Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new publication citation about modifying belantamab mafodotin dosing in DREAMM-7 and DREAMM-8 was added, and the prior Blood Advances citation for the same topic was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-12T06:28:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2 with no visible changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T02:23:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.1 and removed the previous PubMed sourcing phrasing.
    Difference
    0.0%
    Check dated 2025-11-20T22:17:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' and 'MedlinePlus Genetics' as related topics; removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T15:56:55.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No additions or deletions were reported for the page. The visible content and layout appear unchanged with respect to core study details.
    Difference
    0.2%
    Check dated 2025-10-30T11:13:07.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page has updated the disease terminology from 'Plasma cell myeloma' to 'Multiple myeloma' and upgraded the revision to v3.2.0.
    Difference
    0.1%
    Check dated 2025-10-01T02:21:58.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.